Cardiovascular Systems Reports Fiscal 2016 First-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Cardiovascular Systems (CSII) Guides Low 2Q16 Given Lingering Headwinds; Needham & Company Reiterates Buy
November 5, 2015 7:12 AM ESTNeedham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $19.00 (from $18.00), following the company's 1Q16 earnings report. Revenue was $43.9M (up 11% Y/Y after accounting for the end of the Asahi distribution agreement) vs. guidance of $43.9M and EPS was... More
Cardiovascular Systems (CSII) Tops Q1 EPS by 1c
November 4, 2015 4:25 PM ESTCardiovascular Systems (NASDAQ: CSII) reported Q1 EPS of ($0.41), $0.01 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $43.9 million versus the consensus estimate of $43.9 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
... More